8-K Impact 6/10 Debt Issuance

$GH · Guardant Health, Inc.

November 16, 2026 · AI-analyzed SEC filing · Verify material figures against the official SEC.gov filing

Guardant Health completed its private offering of $550M aggregate principal of 0% Convertible Senior Notes due 2032, including full exercise of the $50M initial purchasers' option. Net proceeds were approximately $538.3M. The company used about $501.7M to repurchase $395.2M principal of its existing 0% Convertible Senior Notes due 2027, and $51.7M to fund capped call transactions.

  • Notes carry 0% interest and mature May 15, 2032.
  • Initial conversion price is $208.95, a 35% premium over the $154.78 last sale on Nov 11, 2026.
  • Capped call cap price is $309.56, a 100% premium over the $154.78 reference price.
  • Maximum 3,553,385 shares issuable upon conversion at the initial maximum rate of 6.4607 per $1,000.
  • Notes not redeemable before November 20, 2029 except cleanup redemption.

Extended-hours last trade $145.60, up 1.09% vs regular close, despite a 5.06% regular-session decline. The refinancing of 2027 notes into 2032 notes extends maturity with no interest cost.

Guardant extends its debt maturity to 2032 at zero interest while retiring 2027 notes, reducing near-term refinancing pressure.

Convertible note refinancing with capped calls is a common low-cost financing structure for high-growth diagnostics firms.

Potential dilution of up to 3,553,385 shares upon conversion, partially offset by capped call transactions.

$GH

Get filings like this before the market reacts.

Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.

Start your free trial →